rdf:type |
|
lifeskim:mentions |
umls-concept:C0003320,
umls-concept:C0017262,
umls-concept:C0018787,
umls-concept:C0039194,
umls-concept:C0085358,
umls-concept:C0086418,
umls-concept:C0332448,
umls-concept:C0450127,
umls-concept:C0522536,
umls-concept:C1171362,
umls-concept:C1332717,
umls-concept:C1413235,
umls-concept:C1413244,
umls-concept:C1515670,
umls-concept:C1655270,
umls-concept:C1706438,
umls-concept:C1879547,
umls-concept:C2698600
|
pubmed:issue |
1
|
pubmed:dateCreated |
1992-4-20
|
pubmed:abstractText |
We analyzed the presence of T-cell subsets (CD4/CD8) and the activation markers CD25 and CD69 in the cellular infiltrates of endomyocardium biopsies taken from transplanted human hearts. The results indicate that CD25 was present within specimens mainly infiltrated by CD4+ cells. In contrast, CD69 was found in infiltrated biopsies by CD8+ cells, as determined by single immunofluorescence. Double immunoenzymatic staining was used to investigate the cellular distribution of the activation markers studied in some representative cases. Thus, CD25 was found on both CD4+ and CD8+ cells while CD69 molecule was selectively expressed on CD8+ T-cell subset. These results suggest that CD69 is a surface molecule relevant to the CD8+ cell-mediated graft rejection events of allografted human hearts.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD4,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD8,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/CD69 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Lectins, C-Type,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-2
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0198-8859
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-4
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:1548145-Antigens, CD,
pubmed-meshheading:1548145-Antigens, CD4,
pubmed-meshheading:1548145-Antigens, CD8,
pubmed-meshheading:1548145-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:1548145-Biopsy,
pubmed-meshheading:1548145-Endocardium,
pubmed-meshheading:1548145-Graft Rejection,
pubmed-meshheading:1548145-Heart Transplantation,
pubmed-meshheading:1548145-Humans,
pubmed-meshheading:1548145-Lectins, C-Type,
pubmed-meshheading:1548145-Lymphocyte Activation,
pubmed-meshheading:1548145-Myocardium,
pubmed-meshheading:1548145-Receptors, Interleukin-2,
pubmed-meshheading:1548145-T-Lymphocyte Subsets
|
pubmed:year |
1992
|
pubmed:articleTitle |
The activation antigen CD69 is selectively expressed on CD8+ endomyocardium infiltrating T lymphocytes in human rejecting heart allografts.
|
pubmed:affiliation |
Servicio de Inmunologia, Hospital Universitario Reina Sofia, Facultad de Medicina, Universidad de Cordoba, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|